Literature DB >> 12067309

Increased expression of interleukin-13 but not interleukin-4 in CD4+ cells from patients with the hyper-IgE syndrome.

K O Gudmundsson1, O E Sigurjonsson, S Gudmundsson, D Goldblatt, C M R Weemaes, A Haraldsson.   

Abstract

Hyper IgE syndrome (HIES) is a rare immunodeficiency disorder characterized mainly by high levels of polyclonal IgE in serum and recurrent staphylococcal abscesses of the skin and lungs. The raised IgE levels have led researchers to study the synthesis of cytokines that regulate switching of immunoglobulin production towards IgE such as interleukin-4 (IL-4), IL-12 and interferon-gamma (IFN)-gamma. However, the role of IL-13 in the disease pathogenesis has not been investigated extensively. In this study, we investigated intracellular expression of IL-4 and IL-13 in mononuclear cells and CD4+ cells isolated from patients with HIES and healthy controls. Cells were stained intracellularly with antibodies directed against IL-4 and IL-13 and analysed by flow cytometry before and after activation with PMA and calcium ionophore. The mean proportion of resting or activated IL-4 and IL-13 expressing mononuclear cells were comparable in the two groups as well as the proportion of IL-4 expressing CD4+ cells. In contrast, the mean proportion of IL-13 expressing CD4+ cells was increased significantly in patients with HIES in both the resting and the activated state compared to healthy controls. We conclude that increased expression of IL-13 in CD4+ cells from patients with HIES could account, at least partly, for raised IgE levels in those individuals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12067309      PMCID: PMC1906252          DOI: 10.1046/j.1365-2249.2002.01870.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

Review 1.  IL-13 in allergy: home at last.

Authors:  D B Corry
Journal:  Curr Opin Immunol       Date:  1999-12       Impact factor: 7.486

2.  Interleukin 4 and interferon-gamma secretion by antigen and mitogen-stimulated mononuclear cells in the hyper-IgE syndrome: no TH-2 cytokine pattern.

Authors:  M F Rodríguez; P J Patiño; F Montoya; C J Montoya; R U Sorensen; D García de Olarte
Journal:  Ann Allergy Asthma Immunol       Date:  1998-11       Impact factor: 6.347

3.  Analysis of cytokine signaling in patients with extrinsic asthma and hyperimmunoglobulin E.

Authors:  R L Miller; T M Eppinger; D McConnell; C Cunningham-Rundles; P Rothman
Journal:  J Allergy Clin Immunol       Date:  1998-09       Impact factor: 10.793

4.  Kinetics of intracytoplasmic Th1 and Th2 cytokine production assessed by flow cytometry following in vitro activation of peripheral blood mononuclear cells.

Authors:  L Rostaing; J Tkaczuk; M Durand; C Peres; D Durand; C de Préval; E Ohayon; M Abbal
Journal:  Cytometry       Date:  1999-04-01

5.  Genetic linkage of hyper-IgE syndrome to chromosome 4.

Authors:  B Grimbacher; A A Schäffer; S M Holland; J Davis; J I Gallin; H L Malech; T P Atkinson; B H Belohradsky; R H Buckley; F Cossu; T Español; B Z Garty; N Matamoros; L A Myers; R P Nelson; H D Ochs; E D Renner; N Wellinghausen; J M Puck
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

6.  Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder.

Authors:  B Grimbacher; S M Holland; J I Gallin; F Greenberg; S C Hill; H L Malech; J A Miller; A C O'Connell; J M Puck
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

7.  IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma.

Authors:  T Hoshino; R T Winkler-Pickett; A T Mason; J R Ortaldo; H A Young
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

8.  Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4.

Authors:  C R Yu; R A Kirken; M G Malabarba; H A Young; J R Ortaldo
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

9.  Interleukin-13 inhibits cell proliferation and stimulates interleukin-6 formation in isolated human osteoblasts.

Authors:  A Frost; K B Jonsson; H Brändström; C Ohlsson; S Ljunghall; O Ljunggren
Journal:  J Clin Endocrinol Metab       Date:  1998-09       Impact factor: 5.958

Review 10.  Interleukin-4 and interleukin-13: their similarities and discrepancies.

Authors:  P Chomarat; J Banchereau
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

View more
  3 in total

1.  No indication for a defect in toll-like receptor signaling in patients with hyper-IgE syndrome.

Authors:  E D Renner; I Pawlita; F Hoffmann; V Hornung; D Hartl; M Albert; A Jansson; S Endres; G Hartmann; B H Belohradsky; S Rothenfusser
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

2.  Distinct gene expression patterns of peripheral blood cells in hyper-IgE syndrome.

Authors:  T Tanaka; H Takada; A Nomura; S Ohga; R Shibata; T Hara
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

Review 3.  Hyperimmunoglobulin E syndrome: Genetics, immunopathogenesis, clinical findings, and treatment modalities.

Authors:  Hassan Hashemi; Masoumeh Mohebbi; Shiva Mehravaran; Mehdi Mazloumi; Hamidreza Jahanbani-Ardakani; Seyed-Hossein Abtahi
Journal:  J Res Med Sci       Date:  2017-04-26       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.